Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Long-Term Investments (2016 - 2025)

Ligand Pharmaceuticals' Long-Term Investments history spans 16 years, with the latest figure at $42.0 million for Q3 2025.

  • For Q3 2025, Long-Term Investments rose 285.04% year-over-year to $42.0 million; the TTM value through Sep 2025 reached $42.0 million, up 285.04%, while the annual FY2024 figure was $10.9 million, 208.92% up from the prior year.
  • Long-Term Investments for Q3 2025 was $42.0 million at Ligand Pharmaceuticals, down from $62.1 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $375.0 million in Q2 2021 and bottomed at $3.5 million in Q4 2023.
  • The 5-year median for Long-Term Investments is $35.5 million (2024), against an average of $114.7 million.
  • The largest annual shift saw Long-Term Investments crashed 67.04% in 2024 before it skyrocketed 285.04% in 2025.
  • A 5-year view of Long-Term Investments shows it stood at $375.0 million in 2021, then changed by 0.0% to $375.0 million in 2022, then tumbled by 99.06% to $3.5 million in 2023, then skyrocketed by 208.92% to $10.9 million in 2024, then surged by 285.04% to $42.0 million in 2025.
  • Per Business Quant, the three most recent readings for LGND's Long-Term Investments are $42.0 million (Q3 2025), $62.1 million (Q2 2025), and $18.0 million (Q1 2025).